The Utilization of YouTube as a Resource on Hair Loss Treatments.

Alopecia Baldness Female pattern baldness Hair loss treatment Male pattern baldness YouTube

Journal

Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 03 2020
accepted: 20 05 2020
pubmed: 5 6 2020
medline: 7 1 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

To the best of our knowledge, no previous studies have evaluated the quality of videos discussing hair loss treatments METHODS: YouTube was searched on December 10, 2019, using the relevance and view count filters for the following search terms: hair loss treatment, baldness, alopecia, male pattern baldness, and female pattern baldness. The DISCERN criterion for assessing consumer health information was used to evaluate each video. A score of 1 indicates a low overall video quality, whereas a 5 indicates a high-quality source of information for patients. The DISCERN treatment assessment is a validated tool to assess the quality of patient information about treatment choices. Two-sample t tests and Mann-Whitney U tests were used to determine significance. We analyzed 90 videos receiving a total of 108,240,496 views with a mean view count of 1,202,672 views per video (Table 1). Pharmaceuticals including minoxidil and finasteride were the most commonly mentioned treatment (30% of videos) followed by nutraceuticals (20%). YouTube influencers (Table 2) represented 37.8% of authors followed by companies/advertisers (15.6%). Seventeen videos (18.9%) included board-certified dermatologists. The mean DS overall was 2.66, and the mean DS for bias was 2.98. Our data demonstrate the extensive use of YouTube for hair loss treatment information. While YouTube can be a valuable resource for patients, videos are often biased and can misinform patients. Moreover, the lack of a central review process or governing body to validate claims made in videos can be a safety concern. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Identifiants

pubmed: 32495104
doi: 10.1007/s00266-020-01797-w
pii: 10.1007/s00266-020-01797-w
doi:

Substances chimiques

Pharmaceutical Preparations 0
Minoxidil 5965120SH1

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

1944-1946

Auteurs

Sara Behbahani (S)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA. sb1616@njms.rutgers.edu.

Brittany Ward (B)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA.

Margaret Montovano (M)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA.

Britney N Wilson (BN)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA.

Vaishali Ravikumar (V)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA.

Katrice Karanfilian (K)

Rutgers New Jersey Medical School, 185 South Orange Avenue, Newark, NJ, 07101, USA.

Boris Paskhover (B)

Department of Otolaryngology, Rutgers New Jersey Medical School, 90 Bergen St, Newark, NJ, 07101, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH